NEW YORK (GenomeWeb) – Genedrive announced today that it has partnered with the Foundation for Innovative New Diagnostics (FIND) to begin a study to evaluate the firm's hepatitis C Virus ID Kit.

Genedrive's HCV ID Kit runs on the firm's portable molecular diagnostics platform and is designed for use in low-resource settings, delivering results in 90 minutes. The platform uses PCR amplification and melt curve analysis to rapidly amplify and detect target nucleic acid sequences without the need for nucleic acid isolation.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.